Menu
GeneBe

TNFRSF14

TNF receptor superfamily member 14, the group of CD molecules|Tumor necrosis factor receptor superfamily

Basic information

Region (hg38): 1:2555638-2565382

Links

ENSG00000157873NCBI:8764OMIM:602746HGNC:11912Uniprot:Q92956AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TNFRSF14 gene.

  • not specified (33 variants)
  • Inborn genetic diseases (12 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF14 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
11
clinvar
1
clinvar
12
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 11 1 1

Variants in TNFRSF14

This is a list of pathogenic ClinVar variants found in the TNFRSF14 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-2556673-T-C Benign (Mar 29, 2018)787525
1-2556695-C-T not specified Uncertain significance (Jan 23, 2024)3180244
1-2556701-A-G not specified Uncertain significance (Jan 30, 2024)3180245
1-2556714-A-G not specified not provided (Sep 19, 2013)135349
1-2557726-G-A not specified Uncertain significance (Apr 08, 2022)2282789
1-2557788-G-C not specified Uncertain significance (Jan 17, 2024)3180242
1-2557828-A-C not specified Uncertain significance (Sep 13, 2023)2623122
1-2559013-C-T not specified not provided (Sep 19, 2013)133394
1-2559074-C-G not specified not provided (Sep 19, 2013)133395
1-2559092-C-T not specified not provided (Sep 19, 2013)133396
1-2559110-C-T not specified not provided (Sep 19, 2013)133397
1-2559169-A-G not specified not provided (Sep 19, 2013)133398
1-2559170-T-C not specified not provided (Sep 19, 2013)133399
1-2559347-C-T not specified not provided (Sep 19, 2013)133400
1-2559361-G-T not specified not provided (Sep 19, 2013)133401
1-2559422-G-T not specified not provided (Sep 19, 2013)133402
1-2559426-T-A not specified not provided (Sep 19, 2013)133403
1-2559459-C-A not specified not provided (Sep 19, 2013)133404
1-2559495-C-A not specified not provided (Sep 19, 2013)133405
1-2559503-C-A not specified not provided (Sep 19, 2013)133406
1-2559515-C-T not specified not provided (Sep 19, 2013)133407
1-2559574-C-T not specified not provided (Sep 19, 2013)133408
1-2559622-G-A not specified not provided (Sep 19, 2013)133409
1-2559632-C-G not specified not provided (Sep 19, 2013)133410
1-2559632-C-T not specified not provided (Sep 19, 2013)133411

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TNFRSF14protein_codingprotein_codingENST00000355716 89744
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.8080.192125098031251010.0000120
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6131511740.8690.00001061800
Missense in Polyphen2240.590.54201459
Synonymous-1.239076.31.180.00000576546
Loss of Function3.00214.20.1416.05e-7164

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001850.0000177
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001770.000164

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for BTLA. Receptor for TNFSF14/LIGHT and homotrimeric TNFSF1/lymphotoxin-alpha. Involved in lymphocyte activation. Plays an important role in HSV pathogenesis because it enhanced the entry of several wild-type HSV strains of both serotypes into CHO cells, and mediated HSV entry into activated human T-cells. {ECO:0000269|PubMed:8898196}.; FUNCTION: (Microbial infection) Acts as a receptor for Herpes simplex virus 2/HHV-2. {ECO:0000269|PubMed:11511370, ECO:0000269|PubMed:9696799}.;
Pathway
Cytokine-cytokine receptor interaction - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Costimulation by the CD28 family;Immune System;Adaptive Immune System;TNFs bind their physiological receptors (Consensus)

Recessive Scores

pRec
0.215

Intolerance Scores

loftool
0.186
rvis_EVS
0.13
rvis_percentile_EVS
63.36

Haploinsufficiency Scores

pHI
0.0835
hipred
Y
hipred_score
0.546
ghis
0.454

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.860

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tnfrsf14
Phenotype
hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
positive regulation of cytokine secretion involved in immune response;immune response;cell surface receptor signaling pathway;T cell costimulation;tumor necrosis factor-mediated signaling pathway;negative regulation of alpha-beta T cell proliferation;viral entry into host cell;positive regulation of peptidyl-tyrosine phosphorylation;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium;positive regulation of T cell migration
Cellular component
plasma membrane;external side of plasma membrane;integral component of membrane
Molecular function
virus receptor activity;tumor necrosis factor-activated receptor activity;protein binding;ubiquitin protein ligase binding